argenx SE (ARGX): Price and Financial Metrics


argenx SE (ARGX)

Today's Latest Price: $244.46 USD

5.14 (2.15%)

Updated Sep 17 6:55pm

Add ARGX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 373 in Biotech

See all "A" rated Strong Buy stocks

ARGX Stock Summary

  • With a price/sales ratio of 134.82, Argenx Se has a higher such ratio than 97.74% of stocks in our set.
  • Over the past twelve months, ARGX has reported earnings growth of 640.7%, putting it ahead of 97.55% of US stocks in our set.
  • As for revenue growth, note that ARGX's revenue has grown 374.98% over the past 12 months; that beats the revenue growth of 98.28% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Argenx Se are DNLI, PRQR, FATE, AGIO, and NKTR.
  • ARGX's SEC filings can be seen here. And to visit Argenx Se's official web site, go to www.argenx.com.
ARGX Daily Price Range
ARGX 52-Week Price Range

ARGX Stock Price Chart Technical Analysis Charts


ARGX Price/Volume Stats

Current price $244.46 52-week high $272.74
Prev. close $239.32 52-week low $103.75
Day low $239.40 Volume 233,000
Day high $245.03 Avg. volume 179,591
50-day MA $238.85 Dividend yield N/A
200-day MA $182.71 Market Cap 11.49B

argenx SE (ARGX) Company Bio


arGEN-X N.V., a clinical-stage biopharmaceutical company, focuses on creating and developing therapeutic antibodies for the treatment of cancer and autoimmune diseases. The company was founded in 2008 and is based in Breda, Netherlands.


ARGX Latest News Stream


Event/Time News Detail
Loading, please wait...

ARGX Latest Social Stream


Loading social stream, please wait...

View Full ARGX Social Stream

Latest ARGX News From Around the Web

Below are the latest news stories about Argenx Se that investors may wish to consider to help them evaluate ARGX as an investment opportunity.

argenx SE (ARGX): Hedge Fund Interest Inching Up

The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of June 30th, when the S&P 500 Index was trading around the […]

Yahoo | September 16, 2020

argenx Management to Present at Upcoming Virtual Investor Conferences

September 2, 2020 Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that members of management will participate in several upcoming conferences: * Baird Global Healthcare Conference. Fireside chat on Wednesday, September 9, 2020 at 12:15 p.m. ET. * Morgan Stanley Global Healthcare Conference. Fireside chat on Monday, September 14, 2020 at 1:30 p.m. ET. * BofA Global Healthcare Conference. Fireside chat on Thursday, September 17, 2020 at 10:50 a.m. BST. * Stifel Immunology & Inflammation Summit. Panel on Thursday, October 1, 2020 at 11:00 a.m. ET.Additional information regarding these events will be available on the ...

Yahoo | September 2, 2020

J&J takeout of Momenta lifts argenx SE

Thinly traded argenx SE (ARGX) perks up 1% premarket on light volume on the heels of Johnson & Johnson's (JNJ) $6.5B takeout of Momenta Pharmaceuticals (MNTA).The Belgian biotech's antibody engineering technology is similar to Momenta's, both involving the Fc region where antibodies modulate other cells in the immune system.In May, argenx reported...

Seeking Alpha | August 19, 2020

argenx to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference

August 4, 2020 Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that Tim Van Hauwermeiren, Chief Executive Officer, will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 11, 2020 at 12:35 p.m. ET.A live webcast of the presentation will be available on the Company’s website at www.argenx.com. A replay of the webcast will be available for 90 days following the presentation.About argenx argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology...

Yahoo | August 4, 2020

argenx SE (ARGX) CEO Tim Van Hauwermeiren on Q2 2020 Results - Earnings Call Transcript

argenx SE (ARGX) Q2 2020 Earnings Conference Call July 30, 2020 8:30 AM ET Company Participants Beth DelGiacco - Vice President, Investor Relations Tim Van Hauwermeiren - Chief Executive Officer Keith Woods - Chief Operating Officer Eric Castaldi - Chief Financial Officer Conference Call Participants Yaron Werber - Cowen Yatin...

SA Transcripts on Seeking Alpha | August 2, 2020

Read More 'ARGX' Stories Here

ARGX Price Returns

1-mo 3.10%
3-mo 13.12%
6-mo 105.71%
1-year 93.42%
3-year N/A
5-year N/A
YTD 52.29%
2019 67.09%
2018 52.15%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7467 seconds.